mirtazapine has been researched along with Bone Cancer in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, CC | 1 |
| Cheng, HH | 1 |
| Huang, CJ | 1 |
| Lu, YC | 1 |
| Chen, IS | 1 |
| Liu, SI | 1 |
| Hsu, SS | 1 |
| Chang, HT | 1 |
| Huang, JK | 1 |
| Chen, JS | 1 |
| Jan, CR | 1 |
1 other study available for mirtazapine and Bone Cancer
| Article | Year |
|---|---|
The antidepressant mirtazapine-induced cytosolic Ca2+ elevation and cytotoxicity in human osteosarcoma cells.
Topics: Antidepressive Agents, Tricyclic; Bone Neoplasms; Calcium; Calcium Signaling; Cell Line, Tumor; Cell | 2006 |